Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Bimatoprost SR in Open-angle Glaucoma or Ocular Hypertension
2014-003037-26Phase 3Completed
- Sponsor
- Allergan
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of bimatoprost in open-angle glaucoma (OAG) and ocular hypertension (3 arms), sponsored by Allergan. Primary endpoint: Change in intraocular pressure at time-matched hours. Started Dec 2014; status: completed.
02
Drugs
bimatoprost
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on 2014-003037-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003037-26.